Humankind Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
14,150
+4,080
| +41% | +$452K | 0.38% | 37 |
|
|
2025
Q1 | $1.13M | Sell |
10,070
-2,187
| -18% | -$245K | 0.29% | 51 |
|
|
2024
Q4 | $1.13M | Sell |
12,257
-1,891
| -13% | -$175K | 0.29% | 50 |
|
|
2024
Q3 | $1.19M | Sell |
14,148
-489
| -3% | -$41K | 0.43% | 44 |
|
|
2024
Q2 | $1M | Buy |
14,637
+1,116
| +8% | +$76.6K | 0.27% | 52 |
|
|
2024
Q1 | $990K | Buy |
13,521
+1,683
| +14% | +$123K | 0.26% | 49 |
|
|
2023
Q4 | $959K | Buy |
11,838
+31
| +0.3% | +$2.51K | 0.28% | 50 |
|
|
2023
Q3 | $885K | Buy |
11,807
+344
| +3% | +$25.8K | 0.37% | 39 |
|
|
2023
Q2 | $883K | Buy |
11,463
+799
| +7% | +$61.6K | 0.35% | 41 |
|
|
2023
Q1 | $885K | Sell |
10,664
-126
| -1% | -$10.5K | 0.37% | 41 |
|
|
2022
Q4 | $926K | Sell |
10,790
-3,009
| -22% | -$258K | 0.4% | 37 |
|
|
2022
Q3 | $851K | Buy |
13,799
+1,971
| +17% | +$122K | 0.41% | 35 |
|
|
2022
Q2 | $731K | Sell |
11,828
-1,867
| -14% | -$115K | 0.35% | 42 |
|
|
2022
Q1 | $814K | Buy |
13,695
+1,928
| +16% | +$115K | 0.33% | 40 |
|
|
2021
Q4 | $854K | Buy |
11,767
+1,817
| +18% | +$132K | 1.08% | 28 |
|
|
2021
Q3 | $695K | Buy |
9,950
+1,364
| +16% | +$95.3K | 1.06% | 31 |
|
|
2021
Q2 | $591K | Buy |
8,586
+3,159
| +58% | +$217K | 1.05% | 31 |
|
|
2021
Q1 | $351K | Buy |
+5,427
| New | +$351K | 1.08% | 34 |
|